CH445129A
(fr)
|
1964-04-29 |
1967-10-15 |
Nestle Sa |
Procédé pour la préparation de composés d'inclusion à poids moléculaire élevé
|
US3459731A
(en)
|
1966-12-16 |
1969-08-05 |
Corn Products Co |
Cyclodextrin polyethers and their production
|
US3453257A
(en)
|
1967-02-13 |
1969-07-01 |
Corn Products Co |
Cyclodextrin with cationic properties
|
US3426011A
(en)
|
1967-02-13 |
1969-02-04 |
Corn Products Co |
Cyclodextrins with anionic properties
|
US3453259A
(en)
|
1967-03-22 |
1969-07-01 |
Corn Products Co |
Cyclodextrin polyol ethers and their oxidation products
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
EP0215942B1
(en)
|
1985-03-15 |
1995-07-12 |
Antivirals Inc. |
Polynucleotide assay reagent and method
|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
US5166315A
(en)
|
1989-12-20 |
1992-11-24 |
Anti-Gene Development Group |
Sequence-specific binding polymers for duplex nucleic acids
|
US5185444A
(en)
|
1985-03-15 |
1993-02-09 |
Anti-Gene Deveopment Group |
Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages
|
US5217866A
(en)
|
1985-03-15 |
1993-06-08 |
Anti-Gene Development Group |
Polynucleotide assay reagent and method
|
US5521063A
(en)
|
1985-03-15 |
1996-05-28 |
Antivirals Inc. |
Polynucleotide reagent containing chiral subunits and methods of use
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
US4737323A
(en)
|
1986-02-13 |
1988-04-12 |
Liposome Technology, Inc. |
Liposome extrusion method
|
KR0166088B1
(ko)
|
1990-01-23 |
1999-01-15 |
. |
수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
|
US5539082A
(en)
|
1993-04-26 |
1996-07-23 |
Nielsen; Peter E. |
Peptide nucleic acids
|
US5719262A
(en)
|
1993-11-22 |
1998-02-17 |
Buchardt, Deceased; Ole |
Peptide nucleic acids having amino acid side chains
|
US5714331A
(en)
|
1991-05-24 |
1998-02-03 |
Buchardt, Deceased; Ole |
Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
|
WO1993001286A2
(en)
|
1991-06-28 |
1993-01-21 |
Massachusetts Institute Of Technology |
Localized oligonucleotide therapy
|
EP0786522A2
(en)
|
1992-07-17 |
1997-07-30 |
Ribozyme Pharmaceuticals, Inc. |
Enzymatic RNA molecules for treatment of stenotic conditions
|
US5820873A
(en)
|
1994-09-30 |
1998-10-13 |
The University Of British Columbia |
Polyethylene glycol modified ceramide lipids and liposome uses thereof
|
US5885613A
(en)
|
1994-09-30 |
1999-03-23 |
The University Of British Columbia |
Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
|
US5753613A
(en)
|
1994-09-30 |
1998-05-19 |
Inex Pharmaceuticals Corporation |
Compositions for the introduction of polyanionic materials into cells
|
IL115849A0
(en)
|
1994-11-03 |
1996-01-31 |
Merz & Co Gmbh & Co |
Tangential filtration preparation of liposomal drugs and liposome product thereof
|
US6245747B1
(en)
|
1996-03-12 |
2001-06-12 |
The Board Of Regents Of The University Of Nebraska |
Targeted site specific antisense oligodeoxynucleotide delivery method
|
US7572582B2
(en)
|
1997-09-12 |
2009-08-11 |
Exiqon A/S |
Oligonucleotide analogues
|
US6794499B2
(en)
|
1997-09-12 |
2004-09-21 |
Exiqon A/S |
Oligonucleotide analogues
|
WO1999042091A2
(en)
|
1998-02-19 |
1999-08-26 |
Massachusetts Institute Of Technology |
Use of polycations as endosomolytic agents
|
US7084125B2
(en)
|
1999-03-18 |
2006-08-01 |
Exiqon A/S |
Xylo-LNA analogues
|
PT1178999E
(pt)
|
1999-05-04 |
2007-06-26 |
Santaris Pharma As |
Análogos de l-ribo-lna
|
WO2001047496A1
(en)
|
1999-12-29 |
2001-07-05 |
Mixson A James |
Histidine copolymer and methods for using same
|
US7070807B2
(en)
|
1999-12-29 |
2006-07-04 |
Mixson A James |
Branched histidine copolymers and methods for using same
|
JP2005514005A
(ja)
|
2001-09-04 |
2005-05-19 |
エクシコン エ/エス |
新規のlna組成物およびその使用
|
KR100464261B1
(ko)
|
2002-01-24 |
2005-01-03 |
주식회사 파나진 |
Pna 올리고머를 합성하기 위한 신규한 단량체 및 그의제조방법
|
KR20030084444A
(ko)
|
2002-04-26 |
2003-11-01 |
주식회사 파나진 |
Pna 올리고머를 합성하기 위한 신규한 단량체 및 그의제조방법
|
US7569575B2
(en)
|
2002-05-08 |
2009-08-04 |
Santaris Pharma A/S |
Synthesis of locked nucleic acid derivatives
|
CA2504554A1
(en)
|
2002-11-05 |
2004-05-27 |
Isis Pharmaceuticals, Inc. |
2'-substituted oligomeric compounds and compositions for use in gene modulations
|
AU2004235396B2
(en)
|
2003-04-29 |
2010-11-25 |
Sarepta Therapeutics, Inc. |
Compositions for enhancing transport and antisense efficacy of nucleic acid analog into cells
|
US7211668B2
(en)
|
2003-07-28 |
2007-05-01 |
Panagene, Inc. |
PNA monomer and precursor
|
WO2007047913A2
(en)
*
|
2005-10-20 |
2007-04-26 |
Isis Pharmaceuticals, Inc |
Compositions and methods for modulation of lmna expression
|
HUE036995T2
(hu)
|
2006-05-10 |
2018-08-28 |
Sarepta Therapeutics Inc |
Az alegységek között kationos kötéssel rendelkezõ oligonukleotid analógok
|
MX2009002859A
(es)
*
|
2006-09-15 |
2009-03-30 |
Enzon Pharmaceuticals Inc |
Enlazadores biodegradables a base de ester impedido para suministro de oligonucleotidos.
|
AU2008271050B2
(en)
|
2007-06-29 |
2014-11-06 |
Sarepta Therapeutics, Inc. |
Tissue specific peptide conjugates and methods
|
WO2009008725A2
(en)
|
2007-07-12 |
2009-01-15 |
Prosensa Technologies B.V. |
Molecules for targeting compounds to various selected organs, tissues or tumor cells
|
MX2010004955A
(es)
|
2007-11-15 |
2010-06-30 |
Avi Biopharma Inc |
Metodo de sintesis de oligomeros de morfolina.
|
CA2744987C
(en)
|
2008-12-02 |
2018-01-16 |
Chiralgen, Ltd. |
Method for the synthesis of phosphorus atom modified nucleic acids
|
JP2012523225A
(ja)
|
2009-04-10 |
2012-10-04 |
アソシアシオン・アンスティテュ・ドゥ・ミオロジー |
疾患の処置のためのトリシクロ−dnaアンチセンスオリゴヌクレオチド、組成物及び方法
|
US20110269665A1
(en)
*
|
2009-06-26 |
2011-11-03 |
Avi Biopharma, Inc. |
Compound and method for treating myotonic dystrophy
|
BR112012000828A8
(pt)
|
2009-07-06 |
2017-10-10 |
Ontorii Inc |
Novas pró-drogas de ácido nucleico e métodos de uso das mesmas
|
JP5878758B2
(ja)
|
2009-09-16 |
2016-03-08 |
株式会社Wave Life Sciences Japan |
Rna及びその誘導体合成のための新規保護基
|
CA2805086C
(en)
*
|
2010-05-13 |
2020-10-20 |
Sarepta Therapeutics, Inc. |
Antisense modulation of interleukins 17 and 23 signaling
|
WO2011150408A2
(en)
*
|
2010-05-28 |
2011-12-01 |
Avi Biopharma, Inc. |
Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
|
WO2012039448A1
(ja)
|
2010-09-24 |
2012-03-29 |
株式会社キラルジェン |
不斉補助基
|
JP5831455B2
(ja)
|
2010-09-30 |
2015-12-09 |
日本新薬株式会社 |
モルホリノ核酸誘導体
|
JP5653160B2
(ja)
|
2010-10-15 |
2015-01-14 |
ダンロップスポーツ株式会社 |
ゴルフボール
|
US9161948B2
(en)
*
|
2011-05-05 |
2015-10-20 |
Sarepta Therapeutics, Inc. |
Peptide oligonucleotide conjugates
|
EP2704749A1
(en)
|
2011-05-05 |
2014-03-12 |
Sarepta Therapeutics, Inc. |
Peptide oligonucleotide conjugates
|
IN2014MN00357A
(US07794700-20100914-C00152.png)
|
2011-08-30 |
2015-06-19 |
Medical Res Council |
|
EP2581448B1
(en)
|
2011-10-13 |
2015-01-28 |
Association Institut de Myologie |
Tricyclo-phosphorothioate DNA
|
US9278987B2
(en)
|
2011-11-18 |
2016-03-08 |
Sarepta Therapeutics, Inc. |
Functionally-modified oligonucleotides and subunits thereof
|
ES2935606T3
(es)
*
|
2011-12-08 |
2023-03-08 |
Sarepta Therapeutics Inc |
Análogos de oligonucleótidos dirigidos a LMNA humana
|
CA2862628C
(en)
|
2012-01-27 |
2021-08-24 |
Prosensa Technologies B.V. |
Rna modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy
|
DE102012101676A1
(de)
|
2012-02-29 |
2013-08-29 |
Klaus-Dieter Rösler |
Verfahren und Vorrichtung zum Bearbeiten von Formularen mit einer Datenverarbeitungsanlage
|
KR20220139425A
(ko)
|
2012-07-13 |
2022-10-14 |
웨이브 라이프 사이언시스 리미티드 |
키랄 제어
|
AU2013288048A1
(en)
|
2012-07-13 |
2015-01-22 |
Wave Life Sciences Ltd. |
Asymmetric auxiliary group
|
JP6774333B2
(ja)
*
|
2013-04-16 |
2020-10-21 |
メモリアル スローン ケタリング キャンサー センター |
年齢改変細胞および年齢改変細胞を作製するための方法
|
WO2015108048A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
|
US10322173B2
(en)
|
2014-01-15 |
2019-06-18 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
|
EP3095461A4
(en)
|
2014-01-15 |
2017-08-23 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
|
PT3094728T
(pt)
|
2014-01-16 |
2022-05-19 |
Wave Life Sciences Ltd |
Desenho quiral
|
EP3143141B1
(en)
|
2014-05-16 |
2019-10-02 |
Oregon State University |
Antisense antibacterial compounds and methods
|
JP6687542B2
(ja)
*
|
2014-05-19 |
2020-04-22 |
オレゴン ステート ユニバーシティ |
アンチセンス抗菌化合物および方法
|
WO2015179743A1
(en)
*
|
2014-05-23 |
2015-11-26 |
Genzyme Corporation |
Library and screening approach for improved cell penetrating peptides
|
EA201892467A1
(ru)
*
|
2016-04-29 |
2019-05-31 |
Сарепта Терапьютикс, Инк. |
Олигонуклеотидные аналоги, нацеленные на lmna человека
|